Both in Pharmaceuticals
Atrium Therapeutics vs Korro Bio
Over the past year RNA returned −80.2% and KRRO returned −77.7%; their daily moves had a correlation of 0.02.
RNA −80.2% KRRO −77.7%Growth of $1, one year, split-adjusted
| Metric | RNA | KRRO |
|---|---|---|
| Price | $8.42 | $9.56 |
| Market cap | $144.0M | $140.8M |
| Today | 0.00% | +0.53% |
| 1 month | −38.3% | −25.9% |
| 6 months | −37.9% | −7.0% |
| Year to date | −88.3% | +19.4% |
| 1 year | — | −76.5% |
| Revenue growth (YoY) | −21.9% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −672.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.0× | 59.1× |
| Net cash | $263.9M | $115.0M |
| Dividend yield | — | — |
| Volatility (60d) | 64.4% | 74.5% |
| Short % of float | 20.9% | 13.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).